Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNQ2 | O43526 | 12/20 | 0.40 |
| ▸ | EZH2 | Q15910 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KCNQ3 | O43525 | 8/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3597158 | 0.83 | KCNQ2 (0.39) | KCNQ2EZH2L3MBTL1MEN1KMT2A | |
| SCHEMBL4082475 | 0.83 | EZH2 (0.37) | EZH2MEN1KMT2AALDH1A1 | |
| SCHEMBL3601737 | 0.78 | KCNQ2 (0.38) | KCNQ2L3MBTL1MEN1KMT2AMAOB | |
| SCHEMBL3599822 | 0.77 | KCNQ2 (0.37) | KCNQ2L3MBTL1MEN1KMT2AKCNQ3 | |
| SCHEMBL3597526 | 0.77 | KCNQ2 (0.36) | KCNQ2L3MBTL1MEN1KMT2AMAOB | |
| SCHEMBL3589337 | 0.77 | KCNQ2 (0.39) | KCNQ2EZH2L3MBTL1MEN1KMT2A | |
| SCHEMBL3590506 | 0.76 | KCNQ2 (0.36) | KCNQ2L3MBTL1MEN1KMT2AMAOB | |
| SCHEMBL3607325 | 0.76 | KCNQ2 (0.36) | KCNQ2L3MBTL1MEN1KMT2AMAOB | |
| SCHEMBL3596027 | 0.76 | KCNQ2 (0.51) | KCNQ2L3MBTL1MAOB | |
| SCHEMBL3599090 | 0.75 | KCNQ2 (0.37) | KCNQ2L3MBTL1MEN1KMT2AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024024692-A1 | ACTIVE LIGHT-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, PATTERN FORMATION METHOD, AND ELECTRONIC DEVICE MANUFACTURING METHOD | 富士フイルム株式会社 | 2024-02-01 | — | — | WO | claimed |
| US-10286377-B1 | Electrode array device having an adsorbed porous reaction layer | CUSTOMARRAY, INC. (US) | 2019-05-14 | — | — | US | claimed |
| US-9339782-B1 | Electrode array device having an adsorbed porous reaction layer | CUSTOMARRAY, INC. (US) | 2016-05-17 | — | — | US | claimed |
| US-7718579-B2 | Electrochemical deblocking using a hydrazine derivative | COMBIMATRIX CORPORATION (US) | 2010-05-18 | — | — | US | claimed |
| US-7541314-B2 | Microarray having a base cleavable sulfonyl linker | COMBIMATRIX CORPORATION (US) | 2009-06-02 | — | — | US | claimed |
| EP-1945750-A2 | MICROARRAY HAVING A BASE CLEAVABLE SUCINATE LINKER | Combimatrix Corporation (US) | 2008-07-23 | — | — | EP | claimed |
| US-20080125327-A1 | Bonding amino moieties to solid surface with reactive hydroxyl groups, bonding succinate moieties to the amine groups through amide bonds to form cleavable linkers attached to the solid surface, bonding a succinate group, a sugar group and a base group, synthesizing oligonucleotides | CUSTOMARRAY, INC. | 2008-05-29 | — | — | US | claimed |
| US-20080105541-A1 | Electrode Array Device Having An Adsorbed Porous Reaction Layer | STRATHMANN MICHAEL P | 2008-05-08 | — | — | US | claimed |
| WO-2007100793-A2 | MICROARRAY HAVING A BASE CLEAVABLE SULFONYL LINKER | COMBIMATRIX CORPORATION (US) | 2007-09-07 | — | — | WO | claimed |
| US-20070202509-A1 | Microarray having a base cleavable sulfonyl linker | COMBIMATRIX CORPORATION | 2007-08-30 | — | — | US | claimed |
| US-20060105355-A1 | Electrode array device having an adsorbed porous reaction layer having a linker moiety | KARL MAURER | 2006-05-18 | — | — | US | claimed |
| US-20060102471-A1 | Electrode array device having an adsorbed porous reaction layer | CUSTOMARRAY, INC. | 2006-05-18 | — | — | US | claimed |
| WO-2006031814-A2 | ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE | COMBIMATRIX CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| US-20060054511-A1 | Electrochemical deblocking using a hydrazine derivative | CUSTOMARRAY, INC. | 2006-03-16 | — | — | US | claimed |
| US-5977117-A | Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1999-11-02 | — | — | US | claimed |
| EP-0876364-A2 | SUBSTITUTED PHENYL COMPOUNDS AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-11-11 | — | — | EP | claimed |
| WO-1997025321-A2 | SUBSTITUTED PHENYL COMPOUNDS AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1997-07-17 | — | — | WO | claimed |
| EP-0131161-B1 | HEAT-DEVELOPABLE COLOR PHOTOSENSITIVE ELEMENT | KONICA CORPORATION (JP) | 1988-11-02 | — | — | EP | claimed |
| US-4770989-A | USING A THERMAL SOLVENT AND GELATIN/POLYVINYPYRROLIDONE POLYMER MIXTURE; DIFFUSION TRANSFER QUALITY IMAGE | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1988-09-13 | — | — | US | claimed |
| EP-0131161-A2 | Heat-developable color photosensitive element | KONICA CORPORATION (JP) | 1985-01-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070202509-A1 | Microarray having a base cleavable sulfonyl linker | DPP8, DPP4, SI | KCNQ2 3305/4885EZH2 890/4885L3MBTL1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.